PatentsGlobal
Decoy Therapeutics Broadens Patent Portfolio Across Seven Countries for Multi-Antiviral Innovations
On August 3, 2026, Decoy Therapeutics announced a significant expansion of its intellectual property portfolio, now encompassing seven patent families with 19 pending applications across the U.S., Australia, Canada, China, Europe, Japan, and New Zealand. The portfolio protects its Designable Multi-Antivirals (D-MAVs™)…
Monday, August 3, 2026